{"id":"https://openalex.org/W3096532113","doi":"https://doi.org/10.1182/blood-2020-142228","title":"CXCR4-Expressing Anti-CD25 CAR T-Cells Effectively Eliminate Human AML Cells In Vivo","display_name":"CXCR4-Expressing Anti-CD25 CAR T-Cells Effectively Eliminate Human AML Cells In Vivo","publication_year":2020,"publication_date":"2020-11-04","ids":{"openalex":"https://openalex.org/W3096532113","doi":"https://doi.org/10.1182/blood-2020-142228","mag":"3096532113"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-142228","doi":"https://doi.org/10.1182/blood-2020-142228","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-142228","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038315512","display_name":"Ari Itoh\u2010Nakadai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150921","display_name":"RIKEN Center for Integrative Medical Sciences","ror":"https://ror.org/04mb6s476","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652","https://openalex.org/I4210150921"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ari Itoh-Nakadai","raw_affiliation_strings":["Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan","institution_ids":["https://openalex.org/I4210150921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024059956","display_name":"Yoriko Saito","orcid":"https://orcid.org/0000-0001-5274-558X","observed_orcids":["https://orcid.org/0000-0001-5274-558X"]},"institutions":[{"id":"https://openalex.org/I4210150921","display_name":"RIKEN Center for Integrative Medical Sciences","ror":"https://ror.org/04mb6s476","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652","https://openalex.org/I4210150921"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoriko Saito","raw_affiliation_strings":["Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan","institution_ids":["https://openalex.org/I4210150921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040994389","display_name":"Mariko Tomizawa-Murasawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150921","display_name":"RIKEN Center for Integrative Medical Sciences","ror":"https://ror.org/04mb6s476","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652","https://openalex.org/I4210150921"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mariko Murasawa-Tomizawa","raw_affiliation_strings":["Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan","institution_ids":["https://openalex.org/I4210150921"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hiroshi Kajita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150921","display_name":"RIKEN Center for Integrative Medical Sciences","ror":"https://ror.org/04mb6s476","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652","https://openalex.org/I4210150921"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Kajita","raw_affiliation_strings":["Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan","institution_ids":["https://openalex.org/I4210150921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029833592","display_name":"Takehisa Matsumoto","orcid":"https://orcid.org/0000-0002-4667-9739","observed_orcids":["https://orcid.org/0000-0002-4667-9739"]},"institutions":[{"id":"https://openalex.org/I4210110652","display_name":"RIKEN","ror":"https://ror.org/01sjwvz98","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takehisa Matsumoto","raw_affiliation_strings":["RIKEN Systems and Structural Biology Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RIKEN Systems and Structural Biology Center, Yokohama, Japan","institution_ids":["https://openalex.org/I4210110652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114011162","display_name":"Masashi Matsuda","orcid":"https://orcid.org/0009-0000-7656-5727","observed_orcids":["https://orcid.org/0009-0000-7656-5727"]},"institutions":[{"id":"https://openalex.org/I4210150921","display_name":"RIKEN Center for Integrative Medical Sciences","ror":"https://ror.org/04mb6s476","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652","https://openalex.org/I4210150921"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masashi Matsuda","raw_affiliation_strings":["Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan","institution_ids":["https://openalex.org/I4210150921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029542818","display_name":"Takashi Watanabe","orcid":"https://orcid.org/0000-0002-6184-0375","observed_orcids":["https://orcid.org/0000-0002-6184-0375"]},"institutions":[{"id":"https://openalex.org/I4210150921","display_name":"RIKEN Center for Integrative Medical Sciences","ror":"https://ror.org/04mb6s476","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652","https://openalex.org/I4210150921"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Watanabe","raw_affiliation_strings":["Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan","institution_ids":["https://openalex.org/I4210150921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012045946","display_name":"Mikako Shirouzu","orcid":"https://orcid.org/0000-0002-7997-2149","observed_orcids":["https://orcid.org/0000-0002-7997-2149"]},"institutions":[{"id":"https://openalex.org/I4210110652","display_name":"RIKEN","ror":"https://ror.org/01sjwvz98","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mikako Shirouzu","raw_affiliation_strings":["RIKEN Systems and Structural Biology Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RIKEN Systems and Structural Biology Center, Yokohama, Japan","institution_ids":["https://openalex.org/I4210110652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066057500","display_name":"Osamu Ohara","orcid":"https://orcid.org/0000-0002-3328-9571","observed_orcids":["https://orcid.org/0000-0002-3328-9571"]},"institutions":[{"id":"https://openalex.org/I4210148592","display_name":"Kazusa DNA Research Institute","ror":"https://ror.org/04pnjx786","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210148592"]},{"id":"https://openalex.org/I4210150921","display_name":"RIKEN Center for Integrative Medical Sciences","ror":"https://ror.org/04mb6s476","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652","https://openalex.org/I4210150921"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Osamu Ohara","raw_affiliation_strings":["Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Japan","Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Japan","institution_ids":["https://openalex.org/I4210148592"]},{"raw_affiliation_string":"Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan","institution_ids":["https://openalex.org/I4210150921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087988071","display_name":"Haruhiko Koseki","orcid":"https://orcid.org/0000-0001-8424-5854","observed_orcids":["https://orcid.org/0000-0001-8424-5854"]},"institutions":[{"id":"https://openalex.org/I4210150921","display_name":"RIKEN Center for Integrative Medical Sciences","ror":"https://ror.org/04mb6s476","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652","https://openalex.org/I4210150921"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Haruhiko Koseki","raw_affiliation_strings":["Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan","institution_ids":["https://openalex.org/I4210150921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036394378","display_name":"Leonard D. Shultz","orcid":"https://orcid.org/0000-0002-4868-1031","observed_orcids":["https://orcid.org/0000-0002-4868-1031"]},"institutions":[{"id":"https://openalex.org/I4210115256","display_name":"Jackson Laboratory","ror":"https://ror.org/021sy4w91","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210115256"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leonard Shultz","raw_affiliation_strings":["The Jackson Laboratory, Bar Harbor, ME"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jackson Laboratory, Bar Harbor, ME","institution_ids":["https://openalex.org/I4210115256"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042621361","display_name":"Fumihiko Ishikawa","orcid":"https://orcid.org/0000-0002-8717-1237","observed_orcids":["https://orcid.org/0000-0002-8717-1237"]},"institutions":[{"id":"https://openalex.org/I4210150921","display_name":"RIKEN Center for Integrative Medical Sciences","ror":"https://ror.org/04mb6s476","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210110652","https://openalex.org/I4210150921"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumihiko Ishikawa","raw_affiliation_strings":["Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan","institution_ids":["https://openalex.org/I4210150921"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.2707,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.82051747,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"35","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.847000002861023},{"id":"https://openalex.org/keywords/cd25","display_name":"CD25","score":0.8650000095367432},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9020000100135803},{"id":"https://openalex.org/keywords/cxcr4","display_name":"CXCR4","score":0.9660000205039978},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7739999890327454},{"id":"https://openalex.org/keywords/bone-marrow-homing","display_name":"bone marrow homing","score":0.6830000281333923},{"id":"https://openalex.org/keywords/lentiviral-vectors","display_name":"lentiviral vectors","score":0.6129999756813049},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.6899999976158142},{"id":"https://openalex.org/keywords/off-target-effects","display_name":"off-target effects","score":0.5609999895095825},{"id":"https://openalex.org/keywords/hematopoietic-stem-and-progenitor-cells","display_name":"hematopoietic stem and progenitor cells","score":0.7960000038146973},{"id":"https://openalex.org/keywords/car-t-cell-engineering","display_name":"CAR-T cell engineering","score":0.5230000019073486},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6095945239067078},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5435651540756226},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.5277222394943237},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4655761122703552},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.462380588054657},{"id":"https://openalex.org/C2779468541","wikidata":"https://www.wikidata.org/wiki/Q1334408","display_name":"Severe combined immunodeficiency","level":3,"score":0.45315173268318176},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.45105165243148804},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.43645620346069336},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4363985061645508},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.42447441816329956},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.4103374183177948},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3920924663543701},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3774900436401367},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34561780095100403},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.20273560285568237},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.128681480884552},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.12574061751365662},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-142228","doi":"https://doi.org/10.1182/blood-2020-142228","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-142228","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2054026237","https://openalex.org/W2603659379","https://openalex.org/W4231054744","https://openalex.org/W4389243830","https://openalex.org/W4407977575","https://openalex.org/W3216010390","https://openalex.org/W4319984680","https://openalex.org/W2586220357","https://openalex.org/W4310119528","https://openalex.org/W7133340091"],"abstract_inverted_index":{"Chimeric":[0],"antigen":[1,150,177],"receptor":[2,113],"(CAR)":[3],"T-cells":[4,32,64,222,279,312,400,477,539],"targeting":[5,33,259,467],"CD19":[6],"has":[7],"become":[8],"a":[9,77,105,119,541],"promising":[10,542],"treatment":[11,80,210,543],"option":[12],"for":[13,81,99,121,180,227,545],"relapsed/refractory":[14],"B":[15,23],"cell":[16,162,517],"acute":[17,27],"lymphoblastic":[18],"leukemia":[19,29],"and":[20,38,59,164,175,258,378,402,529,535],"diffuse":[21],"large":[22],"Cell":[24],"lymphoma.":[25,166],"For":[26],"myeloid":[28],"(AML),":[30],"CAR":[31,63,78,268,399,471],"molecules":[34],"such":[35,65,157],"as":[36,66,118,131,158],"CD33":[37],"CD123":[39],"are":[40],"under":[41],"clinical":[42],"evaluation.":[43],"Regardless":[44],"of":[45,62,92,186,211,233,242,260,276,284,290,305,335,380,397,412,459,468,474,494,519,553],"target":[46],"diseases":[47],"or":[48],"antigens,":[49],"it":[50],"is":[51,151,463,540],"essential":[52],"to":[53,75,203,516,555],"understand":[54],"mechanisms":[55],"underlying":[56],"both":[57],"on-":[58],"off-target":[60],"effects":[61],"cytokine":[67],"release":[68],"syndrome.":[69],"In":[70,147,208,367,386],"the":[71,149,238,251,264,381,395,492],"study,":[72],"we":[73,88,196,266,331],"aimed":[74],"develop":[76],"T-cell":[79,201,329,347,358],"poor":[82,122,546],"prognosis":[83,123,547],"AML.":[84,548],"To":[85,255],"this":[86],"end,":[87],"analyzed":[89],"gene":[90],"expression":[91,273],"patient-derived":[93,214,234,298],"AML-initiating":[94,129],"cells":[95,130,138,236,248,262,287,300,338,354,406,426,432,444,449,462,497,502,531],"with":[96,133,218,270,308,343,392,482],"demonstrated":[97,371],"capacity":[98],"in":[100,104,124,128,153,198,231,237,250,263,281,288,302,340,375,408,478,488,491,532],"vivo":[101,209],"AML":[102,213,261,286,299,337,413,461],"development":[103],"NOD/SCID/Il2rgKO":[106],"(NSG)":[107],"xenogeneic":[108,373],"transplantation":[109],"assay.":[110],"CD25":[111,182,469],"(IL-2":[112],"alpha":[114],"chain),":[115],"previously":[116],"reported":[117],"marker":[120],"AML,":[125],"was":[126],"over-represented":[127],"compared":[132],"normal":[134,483],"CD34+CD38-":[135,485],"hematopoietic":[136,405],"stem/progenitor":[137],"(HSPCs)":[139],"(Saito":[140],"et":[141],"al.,":[142],"Science":[143],"Translational":[144],"Medicine":[145],"2010).":[146],"addition,":[148,368],"expressed":[152],"other":[154],"hematologic":[155],"malignancies":[156],"CML,":[159],"adult":[160],"T":[161,194,345,501],"leukemia/lymphoma,":[163],"Hodgkin's":[165],"We":[167],"therefore":[168],"engineered":[169,267],"lentiviral":[170,188],"vector":[171],"containing":[172],"TCR":[173],"sequence":[174],"Fab":[176],"recognition":[178],"sites":[179],"human":[181,193,212,285,460,495],"antigen.":[183],"Following":[184],"transduction":[185],"CD25-CAR":[187,200,220,476,538],"particles":[189],"into":[190],"cord":[191],"blood-derived":[192],"cells,":[195,351,362,365,521,524,526,528],"achieved":[197],"vitro":[199],"expansion":[202],"more":[204],"than":[205],"2x107":[206],"cells.":[207],"xenotransplantation":[215],"(PDX)":[216],"mice":[217,292,341,480],"5x106":[219,277,309],"(25CAR)":[221],"(patient":[223],"n=3,":[224],"PDX":[225,243,291,306,390],"n=3":[226],"each":[228],"patient)":[229],"resulted":[230,280,487],"reduction":[232],"leukemic":[235,247],"peripheral":[239,303],"blood":[240,304],"(PB)":[241],"mice,":[244],"but":[245],"abundant":[246],"remained":[249,301],"bone":[252],"marrow":[253],"(BM).":[254],"improve":[256],"homing":[257],"BM,":[265,534],"construct":[269],"mouse":[271,391,430],"CXCR4":[272,382],"(CXCR4-25CAR).":[274],"Injection":[275,473],"CXCR4-25CAR":[278,344,388,512],"complete":[282,333],"elimination":[283,458],"PB":[289,409,499],"(0.0+/-0.0":[293],"hCD33+":[294,314,321,336],"cells/ml,":[295,424,429,435,442,447,452],"n=3),":[296],"while":[297],"treated":[307,342],"non-CXCR4-expressing":[310],"25CAR":[311,357],"(1416.2+/-661.0":[313],"cells/ml":[315,322],"PB,":[316,323,533],"n=3)":[317],"(Untreated":[318],"PDX:":[319],"15677":[320],"n=1).":[324],"At":[325],"4":[326,506],"weeks":[327,419,507],"post-CAR":[328],"injection,":[330],"found":[332],"eradication":[334],"only":[339],"(CXCR4-25CAR":[346],"treated:":[348,359],"BM":[349,360],"0.0+/-0.0":[350,353,441],"spleen":[352,363],"spleen,":[355],"n=3;":[356,436],"1.9+/-0.4x107":[361],"6.2+/-2.8x107":[364],"n=3).":[366,453],"histopathological":[369],"examination":[370],"no":[372,489],"GVHD":[374],"liver,":[376],"lung,":[377],"intestine":[379],"25":[383],"CAR-treated":[384],"mice.":[385],"one":[387],"T-cell-treated":[389],"longer-term":[393],"observation,":[394],"number":[396],"CXCR4-25":[398],"decreased":[401],"murine":[403],"CD45+":[404,431],"increased":[407],"without":[410],"evidence":[411],"relapse":[414],"after":[415],"3":[416,437],"months":[417,438],"(2":[418],"post-injection:":[420,439,508],"hCD33+AML":[421,440],"1040.3":[422],"+/-159.7":[423],"hCD3+T":[425,443],"474.7":[427],"+/-85.8":[428],"751":[433],"+/-31.0":[434],"136.3":[445],"+/-77.6":[446],"mCD45+":[448],"1864":[450],"+/-428":[451],"These":[454],"findings":[455],"indicate":[456],"that":[457],"mediated":[464],"by":[465,470],"specific":[466],"T-cells.":[472],"CXCR4-expressing":[475,537],"NSG":[479],"engrafted":[481],"CB":[484],"HPSCs":[486],"change":[490],"percentage":[493],"CD3+Foxp3+":[496],"among":[498],"CD4+":[500],"(Pre-injection":[503],"10.5+/-1.4%,":[504],"n=2;":[505],"14.8+/-0.9%":[509],"n=2).":[510],"Additionally,":[511],"did":[513],"not":[514],"affect":[515],"numbers":[518],"CD3+CD4+FoxP3+":[520],"total":[522],"CD3+":[523],"CD19+":[525],"CD33+":[527],"CD56+":[530],"spleen.":[536],"strategy":[544],"Disclosures":[549],"No":[550],"relevant":[551],"conflicts":[552],"interest":[554],"declare.":[556]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2020-11-09T00:00:00"}